These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 7692341

  • 1. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
    Sivam SP.
    Neuropeptides; 1993 Jul; 25(1):35-45. PubMed ID: 7692341
    [Abstract] [Full Text] [Related]

  • 2. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 3. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA, DeLanney LE, Irwin I, Royland JE, Chan P, Jakowec MW, Langston JW.
    Brain Res; 1996 Oct 28; 738(1):53-9. PubMed ID: 8949927
    [Abstract] [Full Text] [Related]

  • 4. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
    Finberg JP, Wang J, Goldstein DS, Kopin IJ, Bankiewicz KS.
    J Neurochem; 1995 Sep 28; 65(3):1213-20. PubMed ID: 7643100
    [Abstract] [Full Text] [Related]

  • 5. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T, Dong B, Ishii K, Kinemuchi H.
    J Neurochem; 1986 Apr 28; 46(4):1277-82. PubMed ID: 2419508
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y, Vaya J, Khatib S, Loboda Y, Finberg JP.
    Neuropharmacology; 2013 Feb 28; 65():48-57. PubMed ID: 22982254
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR, Abercrombie ED.
    J Neurochem; 1994 Jul 28; 63(1):108-17. PubMed ID: 8207420
    [Abstract] [Full Text] [Related]

  • 11. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW.
    J Neurochem; 1990 Sep 28; 55(3):981-8. PubMed ID: 2117053
    [Abstract] [Full Text] [Related]

  • 12. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
    Rothblat DS, Schneider JS.
    Brain Res; 1998 Jan 01; 779(1-2):226-30. PubMed ID: 9473679
    [Abstract] [Full Text] [Related]

  • 13. In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism.
    Brannan T, Prikhojan A, Martínez-Tica J, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1995 Jan 01; 10(2-3):79-89. PubMed ID: 9620056
    [Abstract] [Full Text] [Related]

  • 14. Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release.
    Halladay AK, Kirschner E, Hesse K, Fisher H, Wagner GC.
    Pharmacol Toxicol; 2001 Nov 01; 89(5):237-48. PubMed ID: 11881977
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R, Salem A, Irvine RJ.
    Clin Exp Pharmacol Physiol; 2007 Oct 01; 34(10):1051-7. PubMed ID: 17714093
    [Abstract] [Full Text] [Related]

  • 16. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.
    Hársing LG, Vizi ES.
    Br J Pharmacol; 1984 Nov 01; 83(3):741-9. PubMed ID: 6439273
    [Abstract] [Full Text] [Related]

  • 17. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
    Riederer P, Youdim MB.
    J Neurochem; 1986 May 01; 46(5):1359-65. PubMed ID: 2420928
    [Abstract] [Full Text] [Related]

  • 18. Region-specific alterations in the concentrations of catecholamines and indoleamines in the brains of young and old F344 rats after L-deprenyl treatment.
    ThyagaRajan S, Stevens SY, Felten DL.
    Brain Res Bull; 1999 Mar 15; 48(5):513-20. PubMed ID: 10372512
    [Abstract] [Full Text] [Related]

  • 19. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.
    J Neural Transm (Vienna); 2001 Mar 15; 108(8-9):985-1009. PubMed ID: 11716151
    [Abstract] [Full Text] [Related]

  • 20. Effect of MAO inhibitors on the uptake and metabolism of dopamine in rat and human brain.
    Tekes K, Tóthfalusi L, Gaál J, Magyar K.
    Pol J Pharmacol Pharm; 1988 Mar 15; 40(6):653-8. PubMed ID: 3152003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.